GSEP
ZYME icon

Golden State Equity Partners’s Zymeworks ZYME Stock Holding History

Golden State Equity Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$151K Buy
23,043
+5,250
+30% +$46.8K 0.08% 184
2021
Q4 		$292K Buy
+17,793
New +$371K 0.15% 132

Other funds holding ZYME

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Golden State Equity Partners's ZYME Position: Q1 2022 in Review

Golden State Equity Partners increased its Zymeworks (ZYME) stake by 30% in Q1 2022, buying an estimated $46.8K and bringing the position to 23,043 shares worth $151K. The position accounts for 0.08% of the portfolio, ranked #184.

Golden State Equity Partners first reported a position in ZYME in Q4 2021 and has held it in 2 quarters since. The position peaked at $292K in Q4 2021. 120 funds tracked by Wall St. Rank hold ZYME as of Q1 2022.

  • Golden State Equity Partners held 23,043 shares of Zymeworks worth $151K as of Q1 2022.
  • Golden State Equity Partners bought 5,250 Zymeworks shares in Q1 2022, an estimated $46.8K.
  • Zymeworks made up 0.08% of Golden State Equity Partners's portfolio in Q1 2022, its #184 holding.
  • Golden State Equity Partners first reported a position in Zymeworks in Q4 2021 and has held it in 2 quarters since.
  • Golden State Equity Partners's Zymeworks position peaked at $292K in Q4 2021.
  • 120 funds tracked by Wall St. Rank held Zymeworks as of Q1 2022.

Based on Golden State Equity Partners's 13F filing for Q1 2022, filed 16 May 2022.